Regina LaBelle is a professor and the director of the Addiction and Public Policy Initiative at the Georgetown University Law Center's O’Neill Institute for National and Global Health Law.[1] She was the acting director of the White House Office of National Drug Control Policy (ONDCP) from January 20, 2021 to November 5, 2021, and the only woman to ever lead this office. She was named deputy director and served as acting director by President Joe Biden on the first day of his presidency. Prior to her work with the Biden Administration, she was the Chief of Staff of ONDCP under President Barack Obama.
As Acting Director, LaBelle led the office in developing the Biden Administration’s drug policy priorities, including a historic focus on harm reduction programs in an effort to address the overdose epidemic. LaBelle has testified before the U.S. House and Senate.[2]